Immunotherapy Part 3: Common Controversies and Remaining Questions

SGO on the GO
11/03/2024 17 min
Immunotherapy Part 3: Common Controversies and Remaining Questions

Listen "Immunotherapy Part 3: Common Controversies and Remaining Questions"

Descargar episodio

Episode Synopsis

This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator:Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/NorthwellSpeakers:Erin Zacholski, PharmD, BCOPAssistant Professor - VCU School of PharmacyClinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer CenterSarah Hayward, PharmD, BCOPClinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

More episodes of the podcast SGO on the GO

Part 3: SGO Keeping up with the Chemos: Treatment of Interstitial Lung Disease (ILD) 27/10/2025
Part 2: SGO Keeping up with the Chemos: Prevention and Monitoring of Interstitial Lung Disease (ILD) 27/10/2025
Part 1: SGO Keeping up with the Chemos: Therapies Associated with Interstitial Lung Disease (ILD) 27/10/2025
Cracking the Code, Understanding Time-based Coding 20/10/2025
Cracking the Code, Understanding Risk, Morbidity, and Mortality 05/09/2025
Cracking the Code, Understanding Medical Complexity in Medical Decision Making 10/06/2025
Experiences with Nurse Navigators in Gyn Onc: Part 2 02/05/2025
Experiences with Nurse Navigators in Gyn Onc: Part 1 02/05/2025
Cracking the Code, Understanding Number and Acuity of Diagnosis in Medical Decision Making 10/04/2025
SGO Ways to Wellness: An Open Letter to My Former Self 07/01/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA